John Nuss, Chief Scientific Officer at Ventyx Biosciences, Inc. (VTYX), sold 20,000 shares at $34.64 ($687K) on 2023-06-05, disclosed to the SEC on 2023-06-07.
Open-market sale of $687k VTYX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.29 | 8,322 | $285K | 41.5% |
| 2 | $34.29 | 8,322 | $285K | 41.5% |
| 3 | $34.64 | 1,678 | $58K | 8.5% |
| 4 | $34.64 | 1,678 | $58K | 8.5% |
| Total | $34.35 avg | 20,000 | $687K | 100% |
| Filing → |
| VTYX | SELL | 2024-12-30 | $50K | — | Filing → |
| VTYX | SELL | 2024-12-19 | $30K | — | Filing → |
| VTYX | SELL | 2024-04-03 | $9K | — | Filing → |